The PGY1 pharmacy residency program builds on the Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
Eligibility requirements include a Doctor of Pharmacy degree and ability to obtain licensure in the state of Missouri within 90 days of employment.
About Children's Mercy Kansas City
Children’s Mercy Kansas City (CMKC) is affiliated with the University of Missouri-Kansas City School of Medicine and is the principal teaching hospital for the University of Kansas Medical Center. Additionally, CMKC is ranked one of America’s best hospitals by U.S. News & World Report and is ranked in 10 specialties. CMKC is a level I pediatric trauma center and has the region’s only Level IV, 87 bed Neonatal Intensive Care Unit. The hospital has a 41 bed Pediatric Intensive Care Unit and the division of Hematology, Oncology, and Bone Marrow Transplantation provides care for approximately 2,000 patients a year. The Ward Family Heart Center is one of the highest volume pediatric heart centers in the nation and includes cardiac transplantation and a fetal cardiac program. CMKC has the largest clinical pharmacology program in North America and has more than 140 clinical trials occurring at any one time.